OrthoPediatrics Corp. (KIDS)
- Previous Close
29.94 - Open
29.49 - Bid 30.02 x 100
- Ask 30.47 x 100
- Day's Range
29.45 - 30.62 - 52 Week Range
23.10 - 53.50 - Volume
27,120 - Avg. Volume
169,458 - Market Cap (intraday)
720.722M - Beta (5Y Monthly) 1.18
- PE Ratio (TTM)
-- - EPS (TTM)
-0.92 - Earnings Date May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
40.00
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
www.orthopediatrics.comRecent News: KIDS
Performance Overview: KIDS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KIDS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KIDS
Valuation Measures
Market Cap
712.16M
Enterprise Value
641.91M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.56
Price/Book (mrq)
1.89
Enterprise Value/Revenue
4.32
Enterprise Value/EBITDA
-76.59
Financial Highlights
Profitability and Income Statement
Profit Margin
-14.10%
Return on Assets (ttm)
-3.72%
Return on Equity (ttm)
-5.55%
Revenue (ttm)
148.73M
Net Income Avi to Common (ttm)
-20.97M
Diluted EPS (ttm)
-0.92
Balance Sheet and Cash Flow
Total Cash (mrq)
80.31M
Total Debt/Equity (mrq)
2.93%
Levered Free Cash Flow (ttm)
-34.15M